Hypersensitivity Myocarditis after COVID-19 mRNA Vaccination

Background: Myocarditis, even in a severe and lethal form, may occur after COVID-19 mRNA (BNT162b2) vaccination. However, its pathway, morphomolecular characterization and treatment are still unknown. Methods: Routine hematochemical screening, ECG, Holter monitoring, 2D echocardiogram cardiac magnet...

Descripción completa

Detalles Bibliográficos
Autores principales: Frustaci, Andrea, Verardo, Romina, Galea, Nicola, Lavalle, Carlo, Bagnato, Giulia, Scialla, Rossella, Chimenti, Cristina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8949349/
https://www.ncbi.nlm.nih.gov/pubmed/35329986
http://dx.doi.org/10.3390/jcm11061660

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8949349/
https://www.ncbi.nlm.nih.gov/pubmed/35329986
http://dx.doi.org/10.3390/jcm11061660

Ejemplares similares